What is Asensus Surgical?
Asensus Surgical, Inc. operates at the intersection of robotics, machine vision, and clinical intelligence. By digitizing the interface between the surgeon and the patient, the company is pioneering Performance-Guided Surgery. Its flagship offering, the Senhance Surgical System, is augmented by the Intelligent Surgical Unit (ISU), which provides real-time data analytics and deep learning capabilities. This ecosystem is designed to address the cognitive and economic inefficiencies inherent in traditional laparoscopy, aiming to reduce surgical variability and improve value-based healthcare delivery. As a leader in the medical technology sector, Asensus is systematically transforming the surgical experience from a manual process into a data-driven, intelligent workflow.
How much funding has Asensus Surgical raised?
Asensus Surgical has raised a total of $469M across 19 funding rounds:
Stock Offering
$25M
Multiple Rounds
$45.4M
Debt
$40M
Stock Offering
$23.7M
Multiple Rounds
$55.7M
Share Placement
$31.3M
Other Financing Round
$20M
Stock Issuance/Offering (2016): $25M supported by Lincoln Park Capital
Private Equity (2017): $5.2M featuring SOFAR S.p.A
Stock Issuance/Offering (2017): $23.2M backed by Undisclosed
Debt (2017): $17M with participation from Innovatus Capital Partners
Debt (2018): $40M led by Hercules Capital
Stock Issuance/Offering (2019): $23.7M supported by Undisclosed
Stock Issuance/Offering (2020): $25M featuring Lincoln Park Capital
Stock Issuance/Offering (2020): $15M backed by Undisclosed
Debt (2020): $2M with participation from PPP
Stock Issuance/Offering (2020): $13.7M led by Undisclosed
Share Placement (2021): $31.3M, investors not publicly disclosed
Other Financing Round (2024): $20M featuring KARL STORZ
Key Investors in Asensus Surgical
KARL STORZ
A global leader in endoscopy and medical technology, KARL STORZ provides a vast range of surgical instrumentation and informatics solutions, supporting physicians across virtually all medical specialties.
SV Health Investors
A prominent venture capital firm specializing in early-stage and growth-stage investments within the life sciences and healthcare technology sectors.
Hercules Capital
A leading specialty finance company providing venture debt and growth capital to innovative, high-growth companies in the technology and life sciences industries.
What's next for Asensus Surgical?
With the recent strategic backing, Asensus Surgical is well-positioned to accelerate the deployment of its machine vision and augmented intelligence platforms. The company's roadmap focuses on scaling the adoption of the Senhance system while deepening its integration of deep learning to provide surgeons with unprecedented clinical insights. By leveraging this latest capital, Asensus intends to solidify its competitive moat in the digital surgery market, focusing on long-term value creation and the expansion of its technological footprint in global healthcare systems. The focus remains on achieving consistent, superior surgical outcomes through the continued evolution of its proprietary digital laparoscopy framework.
See full Asensus Surgical company page
